| |JULY 20266Choosing the Right CDMO in India: A 2026 Compliance Guide Choosing the Right CDMO in India: A 2026 Compliance GuideIndia Pharma Startups: Navigating Growth Funding and Market Reality1030ANALYSIS12THOUGHT CENTRALScaling Perfusion Technology from Lab Success to Manufacturing RealityVeerendra Kumar Reddy, General Manager, Enzene Biosciences2434Consumer Trust in OTC Products: The Science Behind SafetyHow CRDMO Leaders can Leverage the BioSecure Act for New OpportunitiesVikas Bansi, Business Director ­ Healthcare, Himalaya Wellness CompanyKapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical ServicesVIVID OUTLOOKAFTERWORDBridging Collaboration Gaps to Boost India's Pharma DiscoveryDr Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis38C O NT E NT S
< Page 5 | Page 7 >